India’s Ayush sector, encompassing Ayurveda, Yoga, Unani, Siddha, and Homoeopathy, achieved a valuation of US$ 18.1 billion in 2020-21, as per the 2021 report titled "Ayush Sector in India: Prospects and Challenges" by the Forum on Indian Traditional Medicine (FITM). This growth reflects the increasing global interest in Indian traditional medicine and robust government policies supporting international cooperation and trade.

Key Growth Drivers in the Ayush Industry

The Ayurveda products market in India has gained momentum due to various government initiatives, such as the "Central Sector Scheme for Promotion of International Cooperation in AYUSH". This scheme incentivizes Ayush manufacturers and institutions to:

• Participate in global trade events, showcasing their products internationally.
• Facilitate the registration of Ayush products with international regulatory bodies.

Additionally, quality certifications such as:

• The WHO Certification of Pharmaceutical Products (CoPP), and
• The AYUSH Premium Mark issued by the Quality Council of India,
  bolster the credibility and competitiveness of Indian Ayurveda products in the global market.

Enhancing Quality Standards in the Ayush Sector

The Ministry of Ayush has launched several programs to ensure that Indian Ayush products meet global standards. One such initiative is the Ayush Oushadhi Gunvatta Evam Uttpadan Samvardhan Yojana (AOGUSY), which focuses on:

• Upgrading pharmacies and drug testing laboratories.
• Strengthening pharmacovigilance frameworks to monitor drug safety.
• Improving regulatory mechanisms for Ayush products.

Moreover, the establishment of the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) ensures adherence to quality benchmarks for ASU&H drugs, aligning them with international standards.

Driving Exports with AYUSHEXCIL

To capitalize on the global demand for Indian traditional medicine, the government has set up the Ayush Export Promotion Council (AYUSHEXCIL). This council:

• Facilitates the export of Ayurveda products and resolves trade challenges.
• Organizes capacity-building programs for stakeholders in the Ayush sector.
• Promotes international cooperation, enabling Indian manufacturers to expand their global footprint.

Ayush Products on the Global Stage

Indian Ayurveda products are increasingly sought after for their effectiveness and adherence to high-quality standards. By obtaining certifications like WHO CoPP and Ayush Premium Mark, manufacturers can access international markets with confidence. The Ministry of Ayush also encourages:

• Research collaborations to validate the therapeutic efficacy of Ayush products.
• Investments in modernizing production facilities to scale output.

Conclusion

The Ayush sector's growth to US$ 18.1 billion in 2020-21 underscores India’s potential to lead the global traditional medicine market. With support from initiatives like AOGUSY, AYUSHEXCIL, and international trade schemes, the sector is poised for exponential growth in the coming years.

The Upcoming IPOs in this week and coming weeks are Transrail Lighting, Mamata Machinery, DAM Capital  Sanathan Textiles, Concord Enviro, Newmalayan Steel, Ventive Hospitality, Senores Pharmaceuticals, Carraro India, Solar91 Cleantech, Unimech Aerospace, Rosmerta Digital, Indo Farm, and Avanse FinancialThe Current active IPO is Identical Brain Studios and NACDAC Infrastructure.
For more details on upcoming IPOs, you can visit our page at Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and stay updated with the latest news on IPO updates on Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance Saathi. Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates. Start your Stock Market Journey and Apply in IPO by opening a Free Demat Account in Choice Broking FinX.